跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dialiptin-25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dialiptin-25
Approved
STANDARD
Dialiptin-25
Beximco Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3247429fe7055d3a
Company
Beximco Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
3247429fe7055d3a
Drug Approval Philippines Name
Dialiptin-25
Product Name
Dialiptin-25
Registration Number
DRP-13435
Brand Name
Dialiptin-25
Generic Name
Sitagliptin (as phosphate)
Dosage Form
Film-Coated Tablet
Dosage Strength
25mg
Manufacturer
Beximco Pharmaceuticals Ltd.
Importer
Macropharma Corporation
Distributor
Macropharma Corporation
Company Detail Path
/organization/beximco-pharmaceuticals-ltd-kaliako
Issuance Date
17 February 2023
Expiry Date
17 February 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3247429fe7055d3a
Type
Standard
Back to Philippines FDA Approvals